Indaptus Therapeutics Inc...

NASDAQ: INDP · Real-Time Price · USD
7.69
-0.12 (-1.54%)
At close: Aug 15, 2025, 12:09 PM

Indaptus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
735.00 1.28K 1.78K 1.4K
Gross Profit
-735 -1.28K -1.78K -1.4K
Operating Income
-15.37M -16.38M -14.91M -7.73M
Interest Income
n/a n/a 588.11K 17.72K
Pretax Income
-15.02M -15.42M -14.32M -7.71M
Net Income
-15.02M -15.42M -14.32M -7.69M
Selling & General & Admin
8.11M 8.76M 8.59M 5.21M
Research & Development
7.25M 7.62M 6.32M 2.52M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
15.37M 16.38M 14.91M 7.73M
Interest Expense
n/a n/a 588.11K n/a
Selling & Marketing Expenses
n/a 100.74K n/a n/a
Cost & Expenses
-15.37M 16.38M 14.91M 7.73M
Income Tax Expense
n/a n/a -588.11K -17.72K
Shares Outstanding (Basic)
9.36M 8.4M 8.26M 4.09M
Shares Outstanding (Diluted)
9.36M 8.4M 8.26M 4.09M
EPS (Basic)
-1.61 -1.84 -1.73 -1.89
EPS (Diluted)
-1.61 -1.84 -1.73 -1.89
EBITDA
-15.02M -16.38M -14.91M -7.73M
EBIT
-15.02M -16.38M -14.91M -7.73M
Depreciation & Amortization
735.00 1.28K 1.78K 1.4K